The Pershing Square Sohn Cancer Research Alliance Celebrates Its 10th Anniversary streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer
USA - English
Share this article
Share this article
NEW YORK, March 3, 2021 /PRNewswire/ Vaxalto Biotherapeutics, Inc. (www.vaxalto.com), a pre-clinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic viruses, and Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine at Mount Sinai, have partnered to develop novel cancer immunotherapies. Mount Sinai has granted an exclusive, worldwide license to Vaxalto covering intellectual property and technology related to an avian paramyxovirus (APMV) oncolytic virus platform and novel immuno-modulator targeting the lymphatic system. This technology forms the core of Vaxalto s proprietary, multimodal therapeutic approach utilizing direct destruction of cancer cells
Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
ZAGREB, Dec 13 (Hina) – Thirty doctors and scientists said in an open letter on Sunday that without vaccination coronavirus would not go away, stressing that based on strict scientific tests they were confident that all approved vaccines would be effective and safe.
“Based on strict tests that are conducted before a vaccine is approved for use, in line with rigorous rules of the medical and scientific communities and regulatory agencies, we are confident that all approved vaccines against COVID-19 will be efficient and safe and that the risk of any serious side effects will be the smallest possible,” the signatories to the letter, including researcher Ivan Djikic, say.